Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long PD dwell

Peritoneal Dialysis International

Volumn 27, Issue 3, 2007, Pages 267-276

  Freida, Philippe ^a   Galach, Magda ^b   Divino Filho, Jose C ^c   Werynski, Andrzej ^b   Lindholm, Bengt ^c  

^a Pasteur Hospital   (France)

^b INSTITUTE OF BIOCYBERNETICS AND BIOMEDICAL ENGINEERING   (Poland)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Glucose; Icodextrin; Sodium; Ultrafiltration

Indexed keywords

CREATININE; DIANEAL; EXTRANEAL; GLUCOSE; ICODEXTRIN; OSMOTIC AGENT; PERITONEAL DIALYSIS FLUID; SODIUM; UREA;

ADULT; AGED; ANURIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CRYSTALLOID; FEMALE; FLUID TRANSPORT; HUMAN; KIDNEY DYSFUNCTION; LONG TERM CARE; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SODIUM EXCRETION; SOLUTE; TRANSPORT KINETICS; ULTRAFILTRATION;

EID: 34250847880     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700311     Document Type: Article

References (34)

1. Khandelwal M, Kothari J, Krishnan M, Liakopoulos V, Tziviskou E, Sahu K, et al. Volume expansion and sodium balance in peritoneal dialysis patients. Part I: Recent concepts in pathogenesis. Adv Perit Dial 2003; 19:36-43.
2. Ates K, Nergizoglu G, Keven K, Sen A, Kutlay S, Erturk S, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60:767-76.
3. Konings CJ, Kooman JP, Schonck M, Dammers R, Cheriex E, Palmans Meulemans AP, et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22:477-87.
4. Tzamaloukas AH, Saddler MC, Murata GH, Mathotra D, Sena P, Simon D, et al. Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol 1995; 6:198-206.
5. Wang T, Lindholm B. Beyond CANUSA, DOQI, ADEMEX: what's next? Perit Dial Int 2002; 22:555-62.
6. Khandelwal M, Kothari J, Krishnan M, Liakopoulos V, Tziviskou E, Sahu K, et al. Volume expansion and sodium balance in peritoneal dialysis patients. Part II: Newer insights in management. Adv Perit Dial 2003; 19:44-52.
7. Medcalf JF, Harris KP, Watts J. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int 2001; 59: 1128-33.
8. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riege LW, et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14:2948-57.
9. Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, et al. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 2005; 16:546-54.
10. Krediet R, Mujais S. Use of icodextrin in high transport ultrafiltration failure. Kidney Int Suppl 2002; 81:S53-61.
11. Lameire N. Volume control in peritoneal dialysis patients: role of newdialysis solutions. Blood Purif 2004; 22:44-54.
12. Posthuma N, ter Wee PM, Verbrugh HA, Oe PL, Peers E, Sayers J, et al. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance. Nephrol Dial Transplant 1997; 12:550-3.
13. Peers E. Icodextrin plus glucose combinations for use in CAPD. Perit Dial Int 1997; 17(Suppl 2):S68-9.
14. Jenkins SB, Wilkie ME. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone. Perit Dial Int 2003; 23:475-80.
15. Dallas F, Jenkins SB, Wilkie ME. Enhanced ultrafiltration using 7.5%icodextrin/1.36% glucose combination dialysate: a pilot study. Perit Dial Int 2004; 24:542-6.
16. Rippe B. Athree-pore model of peritoneal transport. Perit Dial Int 1993; 13(Suppl 2):S35-8.
17. Plum J, Gentile S, Verger C, Brunkhorst R, Bahner U, Faller B, et al. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002; 39:862-71.
18. Wang T, Waniewski J, Heimburger O, Werynski A, Lindholm B. A quantitative analysis of sodium transport and removal during peritoneal dialysis. Kidney Int 1997; 52:1609-16.
19. Flessner M. Effective lymphatic absorption rate is not a useful or accurate term to use in the physiology of peritoneal dialysis. Perit Dial Int 2004; 24:313-16; discussion 316-17.
20. Freida P. Impact of a low sodium dialysate on usual parameters of cardiovascular outcome in anuric patients during APD [Abstract]. Perit Dial Int 1999; 19(Suppl 1):S15.
21. Nakayama M, Yokoyama K, Kubo H, Matsumoto H, Hasegawa T, Shigematsu T, et al. The effect of ultra-low sodium dialysate in CAPD. A kinetic and clinical analysis. Clin Nephrol 1996; 45:188-93.
22. Imholz AL, Koomen GC, Struijk DG, Arisz L, Krediet RT. Fluid and solute transport in CAPD patients using ultralow sodium dialysate. Kidney Int 1994; 46:333-40.
23. Leypoldt JK, Charney DI, Cheung AK, Naprestek CL, Akin BH, Shockley TR. Ultrafiltration and solute kinetics using low sodium peritoneal dialysate. Kidney Int 1995; 48: 1959-66.
24. Heimburger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38:495-506.
25. Freida P, Issad B, Allouache M. Relationships between fill volume, small solute clearances and net ultrafiltration during standardized APD program [Abstract]. Perit Dial Int 1998; 18(Suppl 2):S2.
26. Ho-dac-Pannekeet MM, Schouten N, Langendijk MJ, Hiralall JK, de Waart DR, Struijk DG, et al. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996; 50:979-86.
27. Wilkie ME, Plant MJ, Edwards L, Brown CB. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival. Perit Dial Int 1997; 17:84-7.
28. Freida P. Optimal fluid and sodium removal during long dwell exchange in peritoneal dialysis using bimodal ultrafiltration based on mixed crystalloid and colloid osmosis with a low sodium formulation [Abstract]. Perit Dial Int 2005; 25(Suppl 5):S15.
29. Krishnan M, Liakopoulos V, Passadakis P, Oreopoulos D. Low ultrafiltration with icodextrin after prolonged dwells (14-16 hours), with significant intra and inter-patient variation [Abstract]. J Am Soc Nephrol 2003; 14:481A.
30. Struijk DG, Krediet RT. Sodium balance in automated peritoneal dialysis. Perit Dial Int 2000; 20(Suppl 2):S101-5.
31. Wolfson M, Ogrinc F, Mujais S. Review of clinical trial experience with icodextrin. Kidney Int Suppl 2002; 81: S46-52.
32. Diaz-Buxo JA, Passlick-Deetjen J, Gottoib L. Potential hazards of polyglucose. ASAIO J 2001; 47:602-7.
33. Abu-Alfa AK, Burkart J, Piraino B, Pulliam J, Mujais S. Approach to fluid management in peritoneal dialysis: a practical algorithm. Kidney Int Suppl 2002; 81:S8-16.
34. Galach M, Werynski A, Freida P, Lindholm B. Mathematical modeling of dialysate volume during peritoneal dialysis (PD) with combination fluid - is there anything else besides influence of osmotic agent? [Abstract]. Int J Artif Organs 2006; 29:539.